US President Barack Obama with Indian Prime Minister Manmohan Singh. Official White House Photo by Pete Souza

30 September 2013Americas

India urged to improve its drugs patent policy

India’s drug patent policy has been slammed by US companies who are insisting that action be taken in order to improve trade relations.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Gene tech firm fends off injunction in test kit dispute

Comparing life sciences IP in Brazil and the US

Gilead awarded $30m over counterfeit HIV drug scheme

EPO invalidates human milk patent after Nestle opposition

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

India urged to improve its drugs patent policy

Editor's picks

Editor's picks

More features